News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
Images of health risks make indoor tanning messages more effective
UNC Lineberger's Seth Noar, PhD, and colleagues report in a new study that anti-tanning bed messages with images showing longer-term health effects, such as skin cancer or wrinkles, produced greater negative emotional reactions and higher ratings of effectiveness in a survey of female college students than text-only messages.
UNC Lineberger receives $4 million gift to support promising new cancer treatment
Seeking to help in the development of treatments for metastatic cancer, Alice Lehman of Charlotte has donated $4 million to further the work of UNC Lineberger's new cellular immunotherapy research program.
Cancer burden for aging U.S. HIV population projected to shift
UNC-Chapel Hill researcher Jessica Y. Islam, in collaboration with the National Cancer Institute and Centers for Disease Control and Prevention, reported findings Wednesday at the American Association for Cancer Research Annual Meeting that the total number of HIV-positive cancer patients in the United States is projected to decrease through 2030. She and her collaborators also projected that there would be a decrease in cancers linked to the advanced stage of HIV infection -- AIDS.
UNC Lineberger researchers speak at governor's mansion for launch of Metastatic Breast Cancer Awareness Month
N.C. Gov. Roy Cooper declared April as Metastatic Breast Cancer Awareness Month in North Carolina to bring attention to this second-leading cause of cancer death among women. UNC Lineberger researchers joined First Lady Kristin Cooper at the Executive Mansion on Monday at a luncheon hosted by the North Carolina Oncology Navigator Association.
Nanoparticle treatment could improve immunotherapy against cancer
UNC Lineberger's Andrew Wang, MD, presented preliminary findings at the American Association for Cancer Research Annual Meeting 2017 from a preclinical study into the use of nanoparticles to improve the efficacy of immunotherapy drugs known as checkpoint inhibitors.